How should we inform women at higher risk of breast cancer about tamoxifen? An approach with a decision guide

Breast Cancer Research and Treatment

Volumn 94, Issue 2, 2005, Pages 153-159

  McKay, Andrew ^a,b   Martin, Wanda ^a   Latosinsky, Steven ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Breast cancer prevention; Decision guide; Increased breast cancer risk; Risk reduction; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; E-MAIL; EVALUATION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INFORMED CONSENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT;

BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; FOCUS GROUPS; HUMANS; MANITOBA; MIDDLE AGED; QUESTIONNAIRES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 27544489372     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-6932-6     Document Type: Article

References (21)

1. B Fisher JP Costantino DL Wickerham CK Redmond M Kavanah WM Cronin V Vogel A Robidoux N Dimitrov J Atkins M Daly S Wieand E Tan-Chiu L Ford N Wolmark 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1371 1388
2. M Levine JM Moutquin R Walton J Feightner 2001 Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer CMAJ 164 1681 1690
3. U.S. Preventative Services Task Force: Chemoprevention of Breast Cancer. http://www ahrq gov/clinic/3rduspstf/breastchemo/1-7-2002
4. B Fisher 2000 Re: tamoxifen prevention of breast cancer: an instance of the fingerpost J Natl Cancer Inst 92 659 660
5. AM O'Connor 1989 Effects of framing and level of probability on patients' preferences for cancer chemotherapy J Clin Epidemiol 42 119 126
6. ML Slevin L Stubbs HJ Plant P Wilson WM Gregory PJ Armes SM Downer 1990 Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public BMJ 300 1458 1460
7. ER Port LL Montgomery AS Heerdt PI Borgen 2001 Patient reluctance toward tamoxifen use for breast cancer primary prevention Ann Surg Oncol 8 580 585
8. J Tchou N Hou A Rademaker VC Jordan M Morrow 2004 Acceptance of tamoxifen chemoprevention by physicians and women at risk Cancer 100 1800 1806
9. MH Gail LA Brinton DP Byar DK Corle SB Green C Schairer JJ Mulvihill 1989 Projecting individualized probabilities of developing breast cancer for white females who are being examined annually J Natl Cancer Inst 81 1879 1886
10. S Woloshin LM Schwartz S Byram B Fischhoff HG Welch 2000 A new scale for assessing perceptions of chance: a validation study Med Decis Making 20 298 307
11. BK Rimer JM Schildkraut C Lerman TH Lin J Audrain 1996 Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium Cancer 77 2348 2355
12. C Lerman B Trock BK Rimer A Boyce C Jepson PF Engstrom 1991 Psychological and behavioral implications of abnormal mammograms Ann Intern Med 114 657 661
13. DA Dillman 1978 Mail and Telephone Surveys: The Total Design Method Wiley New York
14. D Stacey AM O'Connor C DeGrasse S Verma 2003 Development and evaluation of a breast cancer prevention decision aid for higher-risk women Health Expect 6 3 18
15. C Zimmermann C Baldo A Molino 2000 Framing of outcome and probability of recurrence: breast cancer patients' choice of adjuvant chemotherapy (ACT) in hypothetical patient scenarios Breast Cancer Res Treat 60 9 14
16. MN Levine A Gafni B Markham D [tmp] MacFarlane 1992 A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer Ann Intern Med 117 53 58
17. RP [tmp] McQuellon HB Muss SL Hoffman G Russell B Craven SB Yellen 1995 Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer J Clin Oncol 13 858 868
18. AM O'Connor NF Boyd P Warde L Stolbach JE Till 1987 Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences J Chronic Dis 40 811 818
19. SB Yellen DF Cella WT Leslie 1994 Age and clinical decision making in oncology patients J Natl Cancer Inst 86 1766 1770
20. A Veronesi MA Pizzichetta MA Ferlante M Zottar MD Magri D Crivellari S Foladore 1998 Tamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatment Tumori 84 372 375
21. JA Tangrea 1997 Patient participation and compliance in cancer chemoprevention trials: issues and concerns Proc Soc Exp Biol Med 216 260 265